发明公开
EP2205083A1 SUBSTITUTED ARYL SULFONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS
有权
取代Arylsulfonderivate作为钙通道阻断剂
- 专利标题: SUBSTITUTED ARYL SULFONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS
- 专利标题(中): 取代Arylsulfonderivate作为钙通道阻断剂
-
申请号: EP08835246.3申请日: 2008-09-30
-
公开(公告)号: EP2205083A1公开(公告)日: 2010-07-14
- 发明人: CHAKRAVARTY, Prasun, K. , DING, Yanbing , DUFFY, Joseph, L. , PAJOUHESH, Hassan , SHAO, Pengcheng Patrick , TYAGARAJAN, Sriram , YE, Feng
- 申请人: Merck Sharp & Dohme Corp. , Neuromed Pharmaceuticals Ltd.
- 申请人地址: 126 East Lincoln Avenue Rahway, NJ 07065 US
- 专利权人: Merck Sharp & Dohme Corp.,Neuromed Pharmaceuticals Ltd.
- 当前专利权人: Merck Sharp & Dohme Corp.,Neuromed Pharmaceuticals Ltd.
- 当前专利权人地址: 126 East Lincoln Avenue Rahway, NJ 07065 US
- 代理机构: Buchan, Gavin MacNicol
- 优先权: US997615P 20071004
- 国际公布: WO2009045382 20090409
- 主分类号: A01N43/40
- IPC分类号: A01N43/40 ; A61K31/445
摘要:
A series of substituted aryl sulfone derivatives represented by Formula I, or pharmaceutically acceptable salts thereof. Pharmaceutical compositions comprise an effective amount of the instant compounds, either alone, or in combination with one or more other therapeutically active compounds, and a pharmaceutically acceptable carrier. Methods of treating conditions associated with, or caused by, calcium channel activity, including, for example, acute pain, chronic pain, visceral pain, inflammatory pain, neuropathic pain, urinary incontinence, itchiness, allergic dermatitis, epilepsy, diabetic neuropathy, irritable bowel syndrome, depression, anxiety, multiple sclerosis, sleep disorder, bipolar disorder and stroke, comprise administering an effective amount of the present compounds, either alone, or in combination with one or more other therapeutically active compounds.
公开/授权文献
信息查询
IPC分类: